← Leaderboards
Reto H.r. Asmis
University Of Kentucky
$9,459,321
Attributed
$9,459,321
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $771.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,459,321 · 4
By mechanism
R01$9,459,321 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Edward D Hall$10,672,048
- Jacqueline Renee Kulbe$171,524
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageAtherosclerosisOxidative StressResponseAtherogenesisMolecularOxidation-ReductionProteinsMonocyteSulfhydryl CompoundsMediatingFunctional DisorderBaseGlutathioneSeveritiesPreventEnzymesMetabolic DiseasesArterial Fatty StreakCardiovascular DiseasesMigrationChronicChemotactic FactorsLink
Grant awards (26)
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis$587,081
R01 · FY2025 · HL · contact PI
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis$658,711
R01 · FY2024 · HL · contact PI
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis$575,575
R01 · FY2023 · HL · contact PI
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis$698,411
R01 · FY2022 · HL · contact PI
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis$704,821
R01 · FY2021 · HL · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$222,936
R01 · FY2017 · AT · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$150,813
R01 · FY2017 · AT · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$373,750
R01 · FY2016 · AT · contact PI
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis$390,991
R01 · FY2015 · HL · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$362,538
R01 · FY2015 · AT · contact PI
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis$389,008
R01 · FY2014 · HL · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$362,538
R01 · FY2014 · AT · contact PI
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis$20,283
R01 · FY2014 · HL · contact PI
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis$377,893
R01 · FY2013 · HL · contact PI
Atheroprotective Mechanisms of Ursolic Acid and Related Phytochemicals$361,228
R01 · FY2013 · AT · contact PI
Nox4 and the Redox-Regulation of MKPs in Monocyte Recruitment and Atherosclerosis$470,504
R01 · FY2012 · HL · contact PI
Glutaredoxin, Macrophage Death and Atherosclerosis$440,792
R01 · FY2010 · HL · contact PI
Glutaredoxin, Macrophage Death and Atherosclerosis$437,309
R01 · FY2009 · HL · contact PI
Glutaredoxin, Macrophage Death and Atherosclerosis$311,250
R01 · FY2008 · HL · contact PI
Glutaredoxin, Macrophage Death and Atherosclerosis$98,189
R01 · FY2008 · HL · contact PI
Glutaredoxin, Macrophage Death and Atherosclerosis$303,900
R01 · FY2007 · HL · contact PI
Role of Glutathione Reductase and Macrophage Oncosis$234,310
R01 · FY2005 · HL
Role of Glutathione Reductase and Macrophage Oncosis$57,690
R01 · FY2005 · HL
Role of Glutathione Reductase and Macrophage Oncosis$289,600
R01 · FY2004 · HL
Role of Glutathione Reductase and Macrophage Oncosis$289,600
R01 · FY2003 · HL
Role of Glutathione Reductase and Macrophage Oncosis$289,600
R01 · FY2002 · HL